69 related articles for article (PubMed ID: 20861608)
1. Is transition zone sampling at repeated saturation prostate biopsy still useful?
Pepe P; Candiano G; Fraggetta F; Galia A; Grasso G; Aragona F
Urol Int; 2010; 85(3):324-7. PubMed ID: 20861608
[TBL] [Abstract][Full Text] [Related]
2. Transition zone index and bothersomeness of voiding symptoms as predictors of early unfavorable outcomes after transurethral resection of prostate.
Milonas D; Saferis V; Jievaltas M
Urol Int; 2008; 81(4):421-6. PubMed ID: 19077403
[TBL] [Abstract][Full Text] [Related]
3. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection by TURP after repeated negative saturation biopsy in patients with persistent suspicion of cancer: a case-control study on 75 consecutive patients.
Pepe P; Fraggetta F; Galia A; Grasso G; Aragona F
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):83-6. PubMed ID: 19901959
[TBL] [Abstract][Full Text] [Related]
5. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
Pepe P; Fraggetta F; Galia A; Grasso G; Piccolo S; Aragona F
Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
[TBL] [Abstract][Full Text] [Related]
6. Lowering the PSA threshold for prostate biopsy from 4 to 2.5 ng/ml: influence on cancer characteristics and number of men needed to biopt.
Müntener M; Kunz U; Eichler K; Puhan M; Schmid DM; Sulser T; Strebel RT
Urol Int; 2010; 84(2):141-6. PubMed ID: 20215816
[TBL] [Abstract][Full Text] [Related]
7. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies.
Radhakrishnan S; Dorkin TJ; Sheikh N; Greene DR
Prostate Cancer Prostatic Dis; 2004; 7(4):338-42. PubMed ID: 15365579
[TBL] [Abstract][Full Text] [Related]
8. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
9. Extended biopsy protocol decreases prostate cancer incidence and risk of aggressive disease on repeated biopsies compared with initial standard procedure.
Ploussard G; Bastien L; Descazeaud A; Robert G; Allory Y; Salomon L; Vordos D; Hoznek A; Yiou R; Abbou CC; de la Taille A
Urol Int; 2010; 84(2):147-52. PubMed ID: 20215817
[TBL] [Abstract][Full Text] [Related]
10. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of transrectal needle biopsy of the prostate: usefulness of systematic 12 core biopsy].
Imazu T; Yokoyama S; Fukuhara S; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2007 Jun; 53(6):365-8. PubMed ID: 17628932
[TBL] [Abstract][Full Text] [Related]
12. The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes.
Elliott CS; Shinghal R; Presti JC
J Urol; 2008 May; 179(5):1756-61; discussion 1761. PubMed ID: 18343425
[TBL] [Abstract][Full Text] [Related]
13. Prostate volume and its correlation with histopathological outcomes in prostate cancer.
Sooriakumaran P; Srivastava A; Bhagat D; John M; Grover S; El-Douaihy Y; Rajan S; Leung R; Tewari A
Urol Int; 2011; 86(2):152-5. PubMed ID: 21228543
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.
Osunkoya AO; Carter HB; Epstein JI
Urology; 2008 Sep; 72(3):638-40. PubMed ID: 18400278
[TBL] [Abstract][Full Text] [Related]
15. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.
Sajadi KP; Kim T; Terris MK; Brown JA; Lewis RW
Urology; 2007 Oct; 70(4):691-5. PubMed ID: 17991539
[TBL] [Abstract][Full Text] [Related]
16. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.
Barzell WE; Melamed MR
Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708
[TBL] [Abstract][Full Text] [Related]
17. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
Ploussard G; Dubosq F; Boublil V; Allory Y; de la Taille A; Vordos D; Hoznek A; Abbou CC; Salomon L
J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
19. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values.
Keetch DW; Catalona WJ
J Urol; 1995 Nov; 154(5):1795-7. PubMed ID: 7563349
[TBL] [Abstract][Full Text] [Related]
20. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
Pepe P; Aragona F
Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
